Ketero

Ketero

ketorolac

Manufacturer:

Akums Drug

Distributor:

Suhitas
Concise Prescribing Info
Contents
Ketorolac tromethamine
Indications/Uses
Short-term management of moderate to severe post-op pain.
Dosage/Direction for Use
IM Adult ≥65 yr or w/ renal failure 10-30 mg, <65 yr 10-60 mg adjusted to severity of pain. Duration of treatment: 2 days. Max: 5 days for severe pain. Childn >2 yr 1 mg/kg. Duration of treatment: 2 days. Multiple dose treatment: Adjusted to severity of pain & patient's response.
Contraindications
Hypersensitivity to ketorolac, aspirin & other NSAIDs. History of asthma, peptic ulceration or GI bleeding; nasal polyps, bronchospasm or angioedema. Moderate or severe renal impairment; hypovolemia or dehydration.
Special Precautions
Not to be given to patients w/ coagulation or hemorrhagic disorders, confirmed or suspected cerebrovascular bleeding. Pregnancy & lactation. Avoid use in childn <2 yr.
Adverse Reactions
GI bleeding, perforation & peptic ulceration; anaphylaxis, rash, bronchospasm, laryngeal edema & hypotension; drowsiness, dizziness, headache, mental & sensory changes, psychotic reactions, sweating, dry mouth, thirst, fever, convulsions, myalgia, aseptic meningitis, HTN, dyspnea, pulmonary edema, bradycardia, chest pain, palpitations, fluid retention, increase in blood urea & creatinine, acute renal failure, edema, hyponatremia, hyperkalemia, urinary frequency/retention, nephrotic syndrome, flank pain w/ or w/o hematuria, purpura, thrombocytopenia, epistaxis, inhibition of platelet aggregation, increased bleeding time, post-op wound hemorrhage, hematoma, flushing/palor & pancreatitis; severe skin reactions including Stevens-Johnson syndrome & Lyell's syndrome; liver function changes, hepatitis & liver failure; pain at the inj site.
Drug Interactions
Not to be given to patients receiving anticoagulants or those requiring prophylactic anticoagulant therapy including low-dose heparin. Increased risk of ketorolac-associated bleeding w/ NSAIDs or aspirin & pentoxifylline. Increased t½ & plasma conc w/ probenecid.
ATC Classification
M01AB15 - ketorolac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Ketero inj 30 mg/mL
Packing/Price
1 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in